BRIEF published on 06/03/2025 at 20:05, 6 months 1 day ago Claranova: Publication of the Number of Shares and Voting Rights Share Capital Voting Rights Financial Regulation Claranova Self-detention
BRIEF published on 05/05/2025 at 21:05, 6 months 30 days ago Claranova: Update on share capital and voting rights Share Capital Voting Rights Actions Regulation Claranova
BRIEF published on 03/27/2025 at 19:10, 8 months 8 days ago Claranova's First-Half Results Show Profitability Growth Profitability Claranova First-half Results Software Publisher PlanetArt Sale
PRESS RELEASE published on 03/27/2025 at 19:05, 8 months 8 days ago Inside Information / News release on accounts, results Claranova reports FY 2024-2025 first-half results with steady revenue around €300m, EBITDA growth of 23%, net income increase to €9.6m, and strategic shift towards software publishing for profitability and debt reduction Financial Results Revenue Debt Reduction Claranova Software Publishing
BRIEF published on 03/05/2025 at 21:05, 8 months 30 days ago Claranova: Publication of the Number of Voting Rights and Shares as of February 28, 2025 Share Capital Voting Rights Self-detention Exercise Of Rights Claranova Actions
BRIEF published on 02/04/2025 at 20:05, 10 months ago Status of Claranova shares and voting rights as of January 2025 Share Capital Voting Rights Actions 2025 Claranova
BRIEF published on 12/24/2024 at 18:05, 11 months 11 days ago Claranova Announces Share Exchange with No Dilution for Shareholders Liquidity Contract Shareholder Value Share Exchange Claranova No Dilution
PRESS RELEASE published on 12/24/2024 at 18:00, 11 months 11 days ago Inside Information / Other news releases Claranova announces non-dilutive share exchange and decrease in liquidity contract funds, safeguarding shareholder value. Reduction in shares for liquidity contract. Company to reestablish liquidity account balance Liquidity Contract Shareholder Value Share Exchange Claranova Non-dilutive
BRIEF published on 12/03/2024 at 20:05, 1 year ago Claranova: Balance Sheet of Shares and Voting Rights as of November 30, 2024 Share Capital Voting Rights Actions Financial Regulation Claranova
BRIEF published on 12/02/2024 at 19:05, 1 year ago Claranova Announces its Financial Calendar for 2025 Euronext Paris Financial Calendar General Meeting Claranova Results 2025
Published on 12/05/2025 at 02:35, 3 hours 37 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 12 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 7 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 12 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 42 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 21 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 47 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 57 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 2 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 12 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 27 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 28 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 11 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
